Alignment Healthcare, Inc. (ALHC)
NASDAQ: ALHC · Real-Time Price · USD
16.15
+0.22 (1.38%)
May 28, 2026, 12:56 PM EDT - Market open
Company Description
Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States.
It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans.
Alignment Healthcare, Inc. was founded in 2013 and is based in Orange, California.
Alignment Healthcare, Inc.
| Country | United States |
| Founded | 2013 |
| IPO Date | Mar 26, 2021 |
| Industry | Healthcare Plans |
| Sector | Healthcare |
| Employees | 1,849 |
| CEO | John Kao |
Contact Details
Address: 1100 West Town and Country Road, Suite 1600 Orange, California 92868 United States | |
| Phone | 844 310 2247 |
| Website | alignmenthealth.com |
Stock Details
| Ticker Symbol | ALHC |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $18.00 |
| CIK Code | 1832466 |
| CUSIP Number | 01625V104 |
| ISIN Number | US01625V1044 |
| Employer ID | 46-5596242 |
| SIC Code | 6324 |
Key Executives
| Name | Position |
|---|---|
| John E. Kao | Founder, Chairman and Chief Executive Officer |
| Joseph Samuel Konowiecki J.D. | Vice Chairman and Executive Vice President of Corporate Affairs |
| Dawn Christine Maroney | President |
| James M. Head | Chief Financial Officer |
| Christopher J. Joyce J.D. | Chief Legal and Administrative Officer |
| Dr. Hyong J. Kim M.D. | Chief Medical Officer |
| Dr. Donald S. Furman M.B.A., M.D. | Co-Founder and Chief Clinical Officer |
| Shane Hochradel | Chief Operations Officer |
| Robert L. Scavo | Chief Information Officer |
| Andreas Wagner | Chief Human Resources Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 15, 2026 | SCHEDULE 13G/A | Filing |
| May 15, 2026 | SCHEDULE 13G/A | Filing |
| May 12, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| May 12, 2026 | 8-K | Current Report |
| May 11, 2026 | 144 | Filing |
| Apr 30, 2026 | 10-Q | Quarterly Report |
| Apr 30, 2026 | 8-K | Current Report |
| Apr 24, 2026 | SCHEDULE 13G/A | Filing |
| Apr 24, 2026 | ARS | Filing |
| Apr 24, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |